Department of Physiology, Dong-A University College of Medicine, Busan 49201, Republic of Korea.
G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Science, 690022 Vladivostok, Russia.
Mar Drugs. 2024 Jul 25;22(8):335. doi: 10.3390/md22080335.
Aquaporins (AQPs) are a family of integral membrane proteins that selectively transport water and glycerol across the cell membrane. Because AQPs are involved in a wide range of physiological functions and pathophysiological conditions, AQP-based therapeutics may have the broad potential for clinical utility, including for disorders of water and energy balance. However, AQP modulators have not yet been developed as suitable candidates for clinical applications. In this study, to identify potential modulators of AQPs, we screened 31 natural products by measuring the water and glycerol permeability of mouse erythrocyte membranes using a stopped-flow light scattering method. None of the tested natural compounds substantially affected the osmotic water permeability. However, several compounds considerably affected the glycerol permeability. Stichoposide C increased the glycerol permeability of mouse erythrocyte membranes, whereas rhizochalin decreased it at nanomolar concentrations. Immunohistochemistry revealed that AQP7 was the main aquaglyceroporin in mouse erythrocyte membranes. We further verified the effects of stichoposide C and rhizochalin on aquaglyceroporins using human AQP3-expressing keratinocyte cells. Stichoposide C, but not stichoposide D, increased AQP3-mediated transepithelial glycerol transport, whereas the peracetyl aglycon of rhizochalin was the most potent inhibitor of glycerol transport among the tested rhizochalin derivatives. Collectively, stichoposide C and the peracetyl aglycon of rhizochalin might function as modulators of AQP3 and AQP7, and suggests the possibility of these natural products as potential drug candidates for aquaglyceroporin modulators.
水通道蛋白(AQP)是一类选择性跨细胞膜转运水和甘油的整合膜蛋白。由于 AQP 参与了广泛的生理功能和病理生理状态,基于 AQP 的治疗方法可能具有广泛的临床应用潜力,包括用于水和能量平衡紊乱的治疗。然而,AQP 调节剂尚未被开发为适合临床应用的候选药物。在这项研究中,为了鉴定 AQP 的潜在调节剂,我们使用停流光散射法测量了小鼠红细胞膜的水和甘油通透性,筛选了 31 种天然产物。测试的天然化合物均未显著影响渗透水通透性。然而,有几种化合物显著影响了甘油的通透性。梓醇 C 增加了小鼠红细胞膜的甘油通透性,而千里光碱则在纳摩尔浓度下降低了其通透性。免疫组织化学显示 AQP7 是小鼠红细胞膜上水通道蛋白的主要甘油通道蛋白。我们进一步使用表达人 AQP3 的角质形成细胞证实了梓醇 C 和千里光碱对水通道蛋白的影响。梓醇 C 而非梓醇 D 增加了 AQP3 介导的跨上皮甘油转运,而千里光碱的乙酰化前体在测试的千里光碱衍生物中是甘油转运的最强抑制剂。总的来说,梓醇 C 和千里光碱的乙酰化前体可能作为 AQP3 和 AQP7 的调节剂发挥作用,并提示这些天然产物作为水通道蛋白调节剂的潜在候选药物的可能性。